The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...
BioDuro has appointed Andrew Thomas (top left) and Stevan Djuric (top right) as Scientific Advisors.
Odyssey Therapeutics, a clinical-stage biopharmaceutical company, has appointed H. Martin Seidel to its Scientific Advisory ...
Imfinzi (durvalumab), in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and ...
L-R: Brian Morrissey, General Manager, Michael Gately, Head of Operations and Declan Hoare, Head of Quality meet with the ...
Incyte Biosciences UK’s Opzelura (ruxolitinib) cream has been approved for reimbursement for eligible patients with ...
As AI drives seismic change across the pharmaceutical industry, its adoption is accompanied by uncertainty and risk.
Inizio Ignite has made five appointments to its key leadership amid the unification of four teams, Research Partnership, ...
Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Leqselvi (deuruxolitinib), made by Sun Pharma UK, as a treatment for severe alopecia areata in adults. Alopecia areata is a ...
Bristol Myers Squibb’s (BMY) Sotyktu has been approved by the US FDA to treat adults with active psoriatic arthritis (PsA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results